News & Topics

2016.11.21 Announcement on the initiation of a new business from the collaboration and commercialization agreement with Steminent Biotherapeutics Inc. for cell therapy

collaboration-and-commercialization-agreement-with-steminent-biotherapeutics

2016.09.20 MEDIAAlvetex wins CV Technology Innovator Awards 2016

ReproCELL is proud to announce its groundbreaking 3D cell culture technology Alvetex has been awarded the Corporate Vision Technology Innovator Award 2016. Read the full interview with Prof. Dr. Stefan Przyborski, ReproCELL Europe’s Chief Scientific Officer and inventor of Alvetex, here: http://reinnervate.com/reprocell-europe-wins-cv-tech-innovator-awards-2016-alvetex/

2016.06.14 ISSCR 2016 Annual Meeting

We will exhibit and presentat a poster at ISSCR 2016 Annual Meeting, San Francisco, USA. We will like to welcome you to stop by our booth and posters. 【 ISSCR 2016 Annual Meeting 】 ■URL: http://www.isscr.org/home/annual-meeting/san-francisco-2016 ■Date: JUNE 22-25, 2016 ■Place: San Francisco, America ■Booth:   ・Date: JUNE 22-25, 2016   ・Booth No.: 1608 ■POSTER   <Ⅰ>   ・Date & Time: JUNE 22, 2016 6:30PM-7:30PM   ・Poster No.: Poster W1093   ・Title: ”Improvement of human iPS cell-derived hepatocyte functionality using 3D culture systems”   ・Presenter: ReproCELL, Inc. Zachary Yu Ching Lin   <Ⅱ>   ・Date & Time: JUNE 22, 2016 7:30PM-8:30PM   ・Poster No.: Poster W2064   ・Title: ”Non-modified RNAs for the derivation of clinically relevant iPS cell lines from adult […]

2016.06.07 11th International ISSX Meeting

We make the presentation a poster at 11th International ISSX Meeting at Busan, Korea. Please stop by at our poster if you attend to the meeting. 【11th International ISSX Meeting】 ■URL: http://issxbusan2016.org/ ■Date: June 12-16, 2016 ■Place: Busan, Korea ■POSTERⅠ   ・Date: June 15, 2016 12:15~13:00 Poster session 2   ・Location: Exhibit Hall (Grand Ballroom – 3F)   ・Poster No.: P52   ・Title: “Stabilized and Enhanced CYP450 Enzyme Activity in Cultured Human Primary Hepatocytes is         Conferred by ReproHP Medium”   ・Host: Sales & Marketing Department Paul CIZDZIEL & Wirtz Julia ■POSTERⅡ   ・Date: June 15, 2016 12:15~13:00 Poster session 2   ・Location: Exhibit Hall (Grand Ballroom – 3F)   ・Poster No.: P232   ・Title: “Improving the prediction of oral bioavailability using fresh […]

2015.11.24 Regarding the synergy effect of making Biopta Limited a wholly-owned subsidiary

Regarding the synergy effect of making Biopta Limited a wholly-owned subsidiary(1) Regarding the synergy effect of making Biopta Limited a wholly-owned subsidiary(2)  

2015.11.18 Notice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’

Notice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’

2015.11.16 PRODUCTA Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

A Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

2015.11.04 Notice of Passage of Examination for United States Patent Application Concerning Amplification Method of Hematopoietic Stem Cells

Notice of Passage of Examination for United States Patent Application Concerning Amplification Method of Hematopoietic Stem Cells

2015.10.19 The ReproCELL Group announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by this corporate group and others.

20151019_The ReproCELL Group announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics”

2015.10.14 The ReproCELL Group announces publication of a paper on its state-of-the-art RNA Reprogramming technology in Human Gene Therapy, an international journal.

The ReproCELL Group announces publication of a paper on its state-of-the-art RNA Reprogramming technology in Human Gene Therapy, an international journal.